Parexel Early Phase Clinical Unit - Los Angeles — Glendale, California

Parexel Early Phase Clinical Unit - Los Angeles is a clinical research site located in Glendale, California, United States 91206.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Parexel Early Phase Clinical Unit - Los Angeles has participated in 4 clinical trials.

Therapeutic areas: Healthy Adults, Healthy Volunteers, Healthy Volunteers - Male and Female.

Sponsors: Kaken Pharmaceutical, Astellas Pharma Europe B.V., PMV Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parexel Early Phase Clinical Unit - Los Angeles?

Parexel Early Phase Clinical Unit - Los Angeles has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parexel Early Phase Clinical Unit - Los Angeles conducted?

Parexel Early Phase Clinical Unit - Los Angeles has 4 clinical trials on record. Their work covers Healthy Adults, Healthy Volunteers, Healthy Volunteers - Male and Female.

Is Parexel Early Phase Clinical Unit - Los Angeles accredited by Crixeo Health?

Parexel Early Phase Clinical Unit - Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parexel Early Phase Clinical Unit - Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.